Brief: Foghorn Therapeutics Securities Provides Significant Cash Runway Into H2 2025
09/01/2023 12:42
Jan 9 (Reuters) - Foghorn Therapeutics Inc. FHTX.O :
* FOGHORN THERAPEUTICS - CASH, CASH EQUIVALENTS & MARKETABLE
SECURITIES OF $373.5 MILLION, AS OF SEPT 30, 2022, PROVIDES
SIGNIFICANT CASH RUNWAY INTO H2 2025
Source text for Eikon: ID:nGNX4QBsvQ
Further company coverage: FHTX.O
((Reuters.Briefs@thomsonreuters.com;))